Pepcid OTC
Executive Summary
Johnson & Johnson/Merck is understood to have filed an NDA to switch the 20 mg dose of Pepcid (famotidine) over-the-counter. The new product could shore up J&J/Merck's position in the heartburn treatment category against the imminent introduction of Procter & Gamble/AstraZeneca's Prilosec OTC. J&J/Merck launched its OTC 10 mg strength Pepcid AC in 1995; 40 mg Pepcid would remain Rx...